Based on this, we proposed that NK cell inhibition derived from the presence of both the KIR2DL2 and KIR2DL3 genes may be weaker that those derived from NK having the presence of the KIR2DL1 gene, and suggested that this reduction in NK cell inhibition was associated with lymphoproliferative disorder. Here, KIR2DL3 is linked to lymphoproliferative syndrome.